The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Cancer Diagnostics-Global Market Insights and Sales Trends 2025

Cancer Diagnostics-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1817738

No of Pages : 85

Ask Your Query

Synopsis

This report mainly covers cancer diagnostics market. Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.

The global Cancer Diagnostics market size is expected to reach US$ 228200 million by 2029, growing at a CAGR of 5.1% from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Diagnostics in various end use industries. The expanding demands from the Breast Cancer, Lung Cancer, Colorectal Cancer and Others, are propelling Cancer Diagnostics market. Platform-based, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Instrument-based segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for Cancer Diagnostics market, driven by demand from China, the second largest economy with some signs of stabilising, the Cancer Diagnostics market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Cancer Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Cancer Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Diagnostics sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Cancer Diagnostics covered in this report include Becton, Dickinson and Company, GE Healthcare, Abbott, Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, Siemens Healthcare and C.R. Bard, etc.

The global Cancer Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Becton, Dickinson and Company
  • GE Healthcare
  • Abbott
  • Roche
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Illumina
  • Siemens Healthcare
  • C.R. Bard

Global Cancer Diagnostics market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Cancer Diagnostics market, Segment by Type:

  • Platform-based
  • Instrument-based

Global Cancer Diagnostics market, by Application

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Cancer Diagnostics
1.1 Cancer Diagnostics Market Overview
1.1.1 Cancer Diagnostics Product Scope
1.1.2 Cancer Diagnostics Market Status and Outlook
1.2 Global Cancer Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cancer Diagnostics Market Size by Region (2018-2029)
1.4 Global Cancer Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Cancer Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cancer Diagnostics Market Size (2018-2029)
1.6.1 North America Cancer Diagnostics Market Size (2018-2029)
1.6.2 Europe Cancer Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Cancer Diagnostics Market Size (2018-2029)
1.6.4 Latin America Cancer Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Cancer Diagnostics Market Size (2018-2029)
2 Cancer Diagnostics Market by Type
2.1 Introduction
2.1.1 Platform-based
2.1.2 Instrument-based
2.2 Global Cancer Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cancer Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Cancer Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cancer Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cancer Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cancer Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cancer Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cancer Diagnostics Revenue Breakdown by Type (2018-2029)
3 Cancer Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Breast Cancer
3.1.2 Lung Cancer
3.1.3 Colorectal Cancer
3.1.4 Others
3.2 Global Cancer Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cancer Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Cancer Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cancer Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cancer Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cancer Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cancer Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cancer Diagnostics Revenue Breakdown by Application (2018-2029)
4 Cancer Diagnostics Competition Analysis by Players
4.1 Global Cancer Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Diagnostics as of 2022)
4.3 Date of Key Players Enter into Cancer Diagnostics Market
4.4 Global Top Players Cancer Diagnostics Headquarters and Area Served
4.5 Key Players Cancer Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Cancer Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Becton, Dickinson and Company
5.1.1 Becton, Dickinson and Company Profile
5.1.2 Becton, Dickinson and Company Main Business
5.1.3 Becton, Dickinson and Company Cancer Diagnostics Products, Services and Solutions
5.1.4 Becton, Dickinson and Company Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Becton, Dickinson and Company Recent Developments
5.2 GE Healthcare
5.2.1 GE Healthcare Profile
5.2.2 GE Healthcare Main Business
5.2.3 GE Healthcare Cancer Diagnostics Products, Services and Solutions
5.2.4 GE Healthcare Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 GE Healthcare Recent Developments
5.3 Abbott
5.3.1 Abbott Profile
5.3.2 Abbott Main Business
5.3.3 Abbott Cancer Diagnostics Products, Services and Solutions
5.3.4 Abbott Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Recent Developments
5.4 Roche
5.4.1 Roche Profile
5.4.2 Roche Main Business
5.4.3 Roche Cancer Diagnostics Products, Services and Solutions
5.4.4 Roche Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Recent Developments
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Profile
5.5.2 Thermo Fisher Scientific Main Business
5.5.3 Thermo Fisher Scientific Cancer Diagnostics Products, Services and Solutions
5.5.4 Thermo Fisher Scientific Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo Fisher Scientific Recent Developments
5.6 Agilent Technologies
5.6.1 Agilent Technologies Profile
5.6.2 Agilent Technologies Main Business
5.6.3 Agilent Technologies Cancer Diagnostics Products, Services and Solutions
5.6.4 Agilent Technologies Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Agilent Technologies Recent Developments
5.7 Illumina
5.7.1 Illumina Profile
5.7.2 Illumina Main Business
5.7.3 Illumina Cancer Diagnostics Products, Services and Solutions
5.7.4 Illumina Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Illumina Recent Developments
5.8 Siemens Healthcare
5.8.1 Siemens Healthcare Profile
5.8.2 Siemens Healthcare Main Business
5.8.3 Siemens Healthcare Cancer Diagnostics Products, Services and Solutions
5.8.4 Siemens Healthcare Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Siemens Healthcare Recent Developments
5.9 C.R. Bard
5.9.1 C.R. Bard Profile
5.9.2 C.R. Bard Main Business
5.9.3 C.R. Bard Cancer Diagnostics Products, Services and Solutions
5.9.4 C.R. Bard Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 C.R. Bard Recent Developments
6 North America
6.1 North America Cancer Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cancer Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cancer Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cancer Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cancer Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cancer Diagnostics Market Dynamics
11.1 Cancer Diagnostics Industry Trends
11.2 Cancer Diagnostics Market Drivers
11.3 Cancer Diagnostics Market Challenges
11.4 Cancer Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock